AKOYA BIOSCIENCES INC (AKYA)

US00974H1041 - Common Stock

4.69  -0.04 (-0.85%)

After market: 4.69 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

AKOYA BIOSCIENCES INC

NASDAQ:AKYA (3/28/2024, 8:00:00 PM)

After market: 4.69 0 (0%)

4.69

-0.04 (-0.85%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap230.47M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AKYA Daily chart

Company Profile

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company is headquartered in Marlborough, Massachusetts and currently employs 369 full-time employees. The company went IPO on 2021-04-16. The firm delivers spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and PhenoImager platforms, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. The company provides PhenoImager HT, which is a digital pathology imager featuring rapid whole-slide multispectral scanning of up to seven colors with an 80-slide capacity. The company offers a contract research services laboratory, which is called Advanced Biopharma Solutions (ABS).

Company Info

AKOYA BIOSCIENCES INC

100 Campus Drive, 6th Floor

Marlborough MASSACHUSETTS

P: 18558968401

CEO: Brian McKelligon

Employees: 369

Website: https://www.akoyabio.com/

AKYA News

News Image24 days ago - InvestorPlaceAKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023

AKYA stock results show that Akoya Biosciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

News Image24 days ago - BusinessInsiderAKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Akoya Biosciences (NASDAQ:AKYA) just reported results for the fourth quarter of...

News Image25 days ago - Akoya Biosciences, Inc.Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
News Image25 days ago - Akoya Biosciences, Inc.Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

Q4 2023 revenue $26.5 million and FY 2023 revenue $96.6 millionGuiding FY 2024 revenue range $114.0-118.0 million and operating cash flow breakeven by YE...

News Image2 months ago - Akoya Biosciences, Inc.Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
News Image2 months ago - Akoya Biosciences, Inc.Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

MARLBOROUGH, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

AKYA Twits

Here you can normally see the latest stock twits on AKYA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example